Equities

Reuters reveals EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal

Reuters reveals EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal

Reuters reported exclusively that the European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development. The move would be the first arranged by the European Union executive since it was mandated by the 27 EU national governments to use an emergency fund of more than 2 billion euros ($2.3 billion) to strike deals with up to six vaccine makers.